ARCA biopharma Announces First Patients Enrolled in ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 (AB201) as a Potential Treatment for COVID-19 Posted on December 15, 2020 by ARCA IT - Press Release, Uncategorized 12.15-rNAPc2-FPE-ASPEN-COVID-Trial
ARCA biopharma Announces Location Change for 2020 Annual Meeting of Stockholders Posted on December 9, 2020 by ARCA IT - Press Release, Uncategorized 12.9-ARCA-Annual-Meeting-Location-Change-FINAL
AB201 Development as a Potential Treatment for COVID-19 Receives U.S. FDA Fast Track Designation Posted on November 23, 2020 by ARCA IT - Press Release, Uncategorized 11.23-AB201-COVID-FDA-Fast-Track-Designation
ARCA biopharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update Posted on November 2, 2020 by ARCA IT - Press Release, Uncategorized 11.2-3Q20-Financial-Results-and-Business-Update
ARCA biopharma Announces FDA Approval of IND Application for AB201 as a Potential Treatment for COVID-19 Posted on October 7, 2020 by ARCA IT - Press Release, Uncategorized 10.07-AB201-COVID-IND-Approval-Study-May-Proceed-FINAL
ARCA biopharma Announces Promotion of Chief Medical Officer and Vice President, Regulatory Affairs & Quality Posted on October 5, 2020 by ARCA IT - Press Release, Uncategorized 10.5-Management-Promotions
ARCA biopharma Announces Submission of IND Application to U.S. FDA for AB201 as a Potential Treatment for COVID-19 Posted on September 21, 2020 by ARCA IT - Press Release, Uncategorized 9.21-AB201-COVID-IND-Submission
ARCA BIOPHARMA ANNOUNCES COMPLETION OF FDA PRE-IND CONSULTATION UNDER CORONAVIRUS TREATMENT ACCELERATION PROGRAM FOR AB201 AS A POTENTIAL TREATMENT FOR SEVERE COVID-19 Posted on August 12, 2020 by ARCA IT - Press Release, Uncategorized AB201-COVID-Pre-IND-Completed
ARCA BIOPHARMA ANNOUNCES SECOND QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Posted on August 5, 2020 by ARCA IT - Press Release, Uncategorized ARCA-2Q20-Financial-Results-and-Business-Update
SARS-CoV-2 Cell Entry Mechanisms in Intact Human Heart Published in JACC: Basic to Translational Science by University of Colorado Anschutz Medical Campus and ARCA biopharma Investigators Posted on July 7, 2020 by ARCA IT - Press Release, Uncategorized ARCA-UC-COVID-19-CV-Paper-Published-JACC-JBTS